Pembrolizumab versus paclitaxel for previously treated, advanced gastric or gastro-oesophageal junction cancer (KEYNOTE-061): a randomised, open-label, controlled, phase 3 trialKohei Shitara, Maria Di Bartolomeo, Mario Mandalà et al.|The Lancet|2018Cited by 1.3k
Modeling of Electronic Health Records for Time-Variant Event Learning Beyond Bio-Markers—A Case Study in Prostate CancerJürgen Herp, Søren P. Sheikh, Manuella Lech Cantuaria et al.|IEEE Access|2023Cited by 8